KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.41 $2.35 Friday, 26th Apr 2024 CYCC stock ended at $1.51. This is 5.63% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.85% from a day low at $1.46 to a day high of $1.56.
90 days $1.41 $3.08
52 weeks $1.41 $13.20

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
Mar 07, 2016 $4.80 $5.64 $4.80 $5.52 20 058
Mar 04, 2016 $4.44 $4.80 $4.44 $4.68 8 750
Mar 03, 2016 $4.44 $5.04 $4.32 $4.32 12 300
Mar 02, 2016 $4.20 $4.32 $4.08 $4.32 4 733
Mar 01, 2016 $4.20 $4.44 $4.08 $4.20 975
Feb 29, 2016 $4.32 $4.44 $4.20 $4.20 3 075
Feb 26, 2016 $4.20 $4.44 $3.96 $4.32 4 742
Feb 25, 2016 $4.44 $4.44 $3.96 $4.32 4 108
Feb 24, 2016 $4.08 $4.20 $3.96 $4.08 11 292
Feb 23, 2016 $3.96 $4.20 $3.84 $4.08 2 042
Feb 22, 2016 $3.84 $4.20 $3.84 $3.96 7 442
Feb 19, 2016 $4.08 $4.08 $3.96 $3.96 4 775
Feb 18, 2016 $3.96 $4.20 $3.96 $4.08 4 958
Feb 17, 2016 $3.84 $4.08 $3.84 $4.08 4 817
Feb 16, 2016 $3.72 $4.08 $3.72 $3.96 2 692
Feb 12, 2016 $3.96 $4.08 $3.72 $3.72 4 825
Feb 11, 2016 $3.84 $4.08 $3.72 $3.72 8 192
Feb 10, 2016 $3.96 $4.08 $3.84 $3.84 7 467
Feb 09, 2016 $3.96 $4.20 $3.72 $3.96 16 458
Feb 08, 2016 $4.32 $4.32 $3.84 $3.84 7 767
Feb 05, 2016 $4.32 $4.56 $4.32 $4.44 2 633
Feb 04, 2016 $4.56 $4.56 $4.32 $4.56 4 050
Feb 03, 2016 $4.44 $4.68 $4.20 $4.56 7 475
Feb 02, 2016 $4.44 $4.56 $4.20 $4.44 3 142
Feb 01, 2016 $4.44 $4.68 $4.20 $4.32 3 392
Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT